EX-23.1 3 tm2217996d1_ex23-1.htm EXHIBIT 23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated March 31, 2022, which includes an explanatory paragraph relating to TransCode Therapeutics, Inc.’s ability to continue as a going concern, relating to the financial statements of TransCode Therapeutics, Inc. appearing in the entity’s Annual Report on Form 10-K for the year ended December 31, 2021. 

/s/ WithumSmith+Brown, PC

East Brunswick, New Jersey

June 9, 2022